Exploring Patient Reported Outcomes in Inherited Ichthyosis
NCT06123091 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2023-11-08
Summary
The goal of this observational study is to learn about the presence of extracutaneous manifestations in patients with congenital ichthyosis.
The main question it aims to answer is:
\- Do patients with congenital ichthyosis experience extracutaneous manifestations?
Participants will fill in questionnaires in which the investigators will explore whether patients experience extracutaneous manifestations, and if so what these manifestations entail. Examples of such questions are whether patients experience (joint) pain or whether they experience hindrance due to their complaints.
Conditions
- Congenital Ichthyosis
Interventions
- OTHER
-
Questionnaires with patient reported outcome measures
Questionnaires to gain insight of the prevalence of extracutaneous manifestations and the impact of the disease on the quality of life.
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Antoni C Gostynski, MD, PhD · Maastricht UMC+
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-10-01
- Completion
- 2024-12-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT00213525 ·Status: COMPLETED
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Observational Study of a Cohort of Patients With Hereditary Epidermolysis Bullosa
NCT04217538 ·Status: COMPLETED
-
Calcinosis in a Single-Center Scleroderma Population
NCT02062125 ·Status: COMPLETED
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Defining the Skin and Blood Biomarkers of Ichthyosis
NCT03417856 ·Status: ENROLLING_BY_INVITATION
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
NCT03041038 ·Status: COMPLETED ·Phase: PHASE2
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
NCT03893643 ·Status: UNKNOWN
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
NCT07183072 ·Status: RECRUITING
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268 ·Status: UNKNOWN
-
Elastography Ultrasound in Localized Scleroderma (Morphea) Study
NCT06847750 ·Status: ENROLLING_BY_INVITATION
-
National Registry for Ichthyosis and Related Disorders
NCT00074685 ·Status: COMPLETED
-
Addressing Inequity in Dermatology
NCT06056648 ·Status: RECRUITING
-
Molecular Effects of Topical Calcipotriene on Morphea
NCT02411643 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
NCT02339441 ·Status: COMPLETED
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Clinical Variability in Marfan Syndrome
NCT01707563 ·Status: COMPLETED ·Phase: NA
-
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
NCT00377949 ·Status: COMPLETED
-
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
NCT02370693 ·Status: COMPLETED ·Phase: PHASE2
-
Personalized Therapy of Patients Suffering From Rare Genodermatoses
NCT05680974 ·Status: UNKNOWN
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA